OBI Pharma Announces Poster Presentations at AACR 2020 Virtual Annual Meeting II

Poster Presentations to highlight the role of the Globo H antigen in cancer cell survival and its prevalence in different tumor types TAIPEI, Taiwan, June 16, 2020/PRNewswire/OBI Pharma, Inc. (TPEx: 4174), a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and SSEA-4), today announced that data highlighting the role of Globo […]

This article is password protected.

To view the content, please enter your password in the field below